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Human platelets respond to various macromolecules in the 
plasma. Uptake of specific ligands, and antibodies to various 
epi topes on the platelet plasma membrane, has been observed. 
The platelet canalicular system has been shown to be involved 
with this uptake. Recently, investigators have speculated on 
the role of endocytosis in platelets to account for the 
presence of plasma proteins such as fibrinogen and 
immunoglobulin within platelet organelles. Antibodies binding 
to cell-surface antigens on platelets can lead to a 
redistribution of these antigens. When antibodies, specific 
for platelet cell-surface receptors, bind to platelets they may 
either undergo endocytosis into intracellular vacuoles, or may 




study investigated whether endocytosis occurs in 
Such a process would lead to the endocytic uptake 
of a fluid-phase marker and would involve internalization and 
recycling of cell surface membrane. 
A fluid-phase marker ( FITC-dextran) was used to measure any 
constitutive endocytic activity. In addition, a suitable 
membrane marker was used to determine whether membrane 
internalization occurred. This involved a technique whereby 
radioactive galactose was covalently attached to cell-surface 
glycoconjugates. 
iv 
A monoclonal antibody to the platelet receptor, GPIIbIIIa, was 
used in conjunction with the membrane marker in order to 
determine if membrane internalization was involved during the 
subsequent redistribution of the receptor-antibody complex. 
Immunocytochemical techniques using electron-dense probes were 
employed to localise the sites to which this receptor-antibody 
complex became redistributed. 
In comparison with reported rates of endocytic uptake of fluid-
phase marker in other cell types, no significant endocytic 
activity could be detected with platelets, after taking their 
relatively small volume into account. Similarly, membrane 
internalization was not detected with resting platelets. 
Following challenge of the platelets with anti-GPIIbIIIa 
antibody, no membrane internalization could be.measured during 
redistribution of the receptor-antibody complex. 
The compartment to 
redistributed could 
canalicular system. 
which the receptor-antibody complex 
be identified morphologically as 
was 
the 
The present data provide evidence for a process of 
sequestration of receptor-antibody in the canalicular system of 
resting platelets. It remains possible that other mechanisms 
exist within the platelet system for uptake of extracellular 
material as this study dealt exclusively with the platelet 
response to a specific antibody. These results may have 
implications with respect to the interaction of platelets with 
anti-platelet antibodies in the normal state, as well as with 
V 
clinical disorders involving elevated levels of platelet-
associated IgG. 
As far as can be deduced from the available literature, these 
data represent the first use of a covalent membrane marker in 
conjunction with uptake of macromolecules to study endocytic 
events in human platelets. 
vi 
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The aim of this thesis was to gain quantitative and qualitative 
information about the membrane events that lead to uptake of 
extracellular material in human platelets. Also, to describe 
any constitutive endocytic activity occurring with normal 
platelets in the resting state, using assays for measuring 
fluid-phase uptake and membrane labelling techniques. These 
techniques will be used in conjunction with a monoclonal 
antibody to a platelet membrane receptor, to determine whether 
or not endocytosis occurred during redistribution of the 
receptor antibody complex. Before discussing evidence relating 
to this question it is necessary to describe platelet 
morphology and other relevant aspects. 
1.1 PLATELET MORPHOLOGY 
Blood platelets are derived from megakaryocytes. The mechanism 
by which they are formed and released into the circulation is 
still subject to controversy, but probably involves the network 
of tubules and fissures that communicate with the surface of 
the megakaryocyte and 







megakaryocyte development is presented by Hovig (1). 
the 
of 
The human platelet, an apparently simple cell lacking a 
nucleus, has a discoid shape in the circulation and is 
relatively small, with dimensions of about 3,6 x 0,9 µm. The 
volume of platelets varies, with a mean of 5,2 to 7,7 µ3 (3). 
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The cytoplasmic content of platelets has great similarities to 
that of the parent cell. A schematic diagram summarizing some 
of the more prominent structures observed in human platelets is 
depicted in Figure 1. Unlike cells such as leucocytes and 
macrophages, which have a surface characterized by villous 
projections and ridges, the platelet surface is smooth. The 
plasma membrane is enriched in membrane proteins, a higher 
proportion of which is located on the exoplasmic face of the 
membrane when compared to other cell types (1). This relates 
to the platelets' role in the recognition of surfaces and 
agonists involved with platelet activation (cf. 1.2.1). 
The platelet has a cytoskeleton of filaments and microtubules. 
Actin filaments constitute a large percentage of the total 
protein. Filaments are rearranged and polymerized for 
pseudopod extension and for the contractile process that 
squeezes the granules towards the cell centre during surf ace 
activation. A peripheral band of microtubules is important for 
the maintenance of the discoid shape in the resting state (1). 
The platelet has ex-granules, containing various proteins and 
growth factors, dense granules, and glycogen particles. Lipid 
droplets may be seen, as well as the occasional mitochondrion 
or remnants of Golgi apparatus (1,4,5). 
There is a network of tubules that ramify throughout the 
cytoplasm, the membranes of which are in continuity with the 
plasma membrane. This forms the open canalicular system (CS) 
which is in communication with the surrounding medium (2), and 
3 
can be seen as a network of small vacuoles or tubules in 
ul trathin sections of platelets (cf. Figure 1) . The three-
dimensional reconstruction of the CS by Kawakami and Hirano (6) 
allows a perspective of the CS as a whole, including the 
opening, or pore, on the plasma membrane. The CS membranes 
cannot be referred to as true, internal membranes, because they 
are in continuity with the plasma membrane, but they retain a 
degree of individuality with respect to their glycoprotein 
composition (7). 
It has been suggested that the CS represents a reservoir of 
sequestered membranes that can be evaginated following platelet 
activation (8). On the other hand, others believe that the CS 
cannot contribute to increased plasma membrane surface area 
during spreading. They argue that the CS would have to be torn 
apart for the membranes to undergo evagination (9). 
The role of the CS in platelet secretion is controversial. It 
has long been upheld that the CS can serve as a route for 
uptake and secretion ( 7-12). Discharge of granular contents 
into the CS during secretion has been questioned as bovine 
platelets, while showing normal secretion, are almost devoid of 
CS (13). The potential importance of the CS in human platelets 
as sequestering uni ts is great. Circulating platelets in an 
adult represent a membrane surface area of about 25 m2, to 
which should be added the area of the extensive CS (10). 
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1.2 PLATELET MEMBRANE PROTEINS 
1.2.1 Functions 
Platelets are responsible for the initiation of and the 
structural basis for the haemostatic plug which prevents 
bleeding. The cell undergoes transformation to a form which 
adheres to other platelets and to surfaces, secreting a variety 
of mediators. In doing this, the platelet expresses binding 
sites for adhesive macromolecules on the plasma membrane (14). 
A variety of platelet interactions are required for haemostasis 
and thrombosis to occur, many of which involve membrane 
proteins. Most of these proteins are glycoprotein receptors, 
as platelet function depends primarily on adhesion events. The 
interactions of platelets are specialised adaptations of 
adhesive mechanisms used by a wide variety of cells (15). 
1.2.2 The platelet GPIIbIIIa 
The glycoprotein IIbIIIa complex comprises proteins of the 
integrin receptor family (15). The complex is composed of one 
molecule of GPIIb (140 kD) which consists of disulfide-linked 
light and heavy chains, and one molecule of GPIIIa (150 kD). 
The complex is present as a ca2+_dependent heterodimer 
consisting of a globular head domain and two tail domains, the 
tips of which constitute the hydrophobic sites associated with 
the membrane. There are two short cytoplasmic domains (15). 
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On activated platelets, the GPIIbIIIa complex serves as a 
receptor for f ibrinogen, f ibronectin, von Willebrand factor, 
vitronectin, and thrombospondin, and mediates platelet 
aggregation, adhesion and spreading ( 15). Normal platelets 
contain about 50 000 molecules of the complex, randomly 
distributed on the surface of resting platelets (14,15). An~-
granule pool of GPIIbIIIa has also been identified and is 
associated with the granule membrane ( 16). The complex is 
present on megakaryocyte membranes with a similar, random 
distribution as on resting platelets (17). 
1.2.3 Interactions between membrane glycoproteins and the 
platelet cytoskeleton 
Many cell-surf ace glycoproteins are known to interact in a 
transmembrane manner with the cell cytoskeleton, especially 
after aggregation of the proteins by multivalent ligands. As 
well as actin, the cytoskeleton has myosin and actin binding 
protein (18). In addition to activating agents such as 
thrornbin, ligands (e.g. concanavalin A) can induce interaction 
between surface glycoproteins and the internal cytoskeleton 
( 19). In surface-activated platelets, bound fibrinogen 
undergoes redistribution on the cell surf ace accompanied by 
cytoskeletal reorganisation, suggesting a link between surface 
receptors and the cytoskeleton (20,21). 
Subsequent studies confirm the receptor-cytoskeleton link 
(22,23), demonstrating that the use of actin depolymerization 
agents (e.g. cytochalasin B) causes previously redistributed, 
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clustered receptors to form a patch-like pattern, a process 
thought not to be passive ( 22). Interactions of platelet 
surface glycoproteins with the cell cytoskeleton thus play an 
important role during receptor-ligand redistribution on resting 
and activated platelets. 
1.2.4 Interactions between monoclonal antibodies and 
membrane glycoproteins 
In addition to ligand-induced receptor reorganization, binding 
of specific antibodies to one of various platelet surface 
antigens results 
redistribution (24). 
in receptor mobility and organized 
Monoclonal antibody induced activation of 
platelets involves Fe receptor-dependent cell-cell interactions 
(25). Another reported finding is that activation of platelets 
by a monoclonal antibody to GPIIbIIIa involves cross-linking of 
an Fe receptor with GPIIbIIIa (26-28). 
Even when platelets are in the resting state, antibodies 
directed against membrane receptors are redistributed to 
pronase-resistant, intracellular sites (29). A study involving 
monoclonal antibodies to platelet GPib and GPIIbIIIa ( chosen 
because of their importance in platelet immune interactions) 
showed that antibody binding results in redistribution of 
GPIIbIIIa, whereas GPib does not redistribute. The 
redistribution of GPIIbIIIa occurred in a patch-cap manner 
followed by apparent internalization (24). This was postulated 
to have a role in the clearing of anti-platelet antibodies (in 
a membrane clearing process) by the process of endocytosis. 
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1.3 EVIDENCE RELATING TO ENDOCYTIC ACTIVITY IN PLATELETS 
Receptor-mediated and fluid-phase endocytosis via coated pits 
and coated vesicles provides a general mechanism for selective 
uptake of specific macromolecules into cells from the 
surrounding fluid (30,31). Platelets have a great deal of 
membrane surface area in contact with the surrounding plasma, 
especially if the membranes of the canalicular system are taken 
into account. The importance of platelets as internalizing 
elements of the blood is potentially great, considering the 
high density of receptors contained in the platelet plasma 
membrane and the significance of platelet-macromolecule 
interactions. This includes interactions with anti-platelet 
I gG ( 2 4 , 3 2 ) . 
1.3.1 Phagocytosis, receptor-ligand redistribution and the 
canalicular system 
There have been many studies claiming to demonstrate phagocytic 
activity with human platelets using markers such as large and 
small latex particles, colloidal carbon, thorium and cationised 
ferri tin ( 9, 33-36). An early study demonstrates that latex 
particles are not phagocytosed in the usual sense, but are 
instead sequestered in the channels of the canalicular system 
(CS) ( 12). Another study subsequently demonstrates acid 
phosphatase activity in the latex-containing "organelles", 
pointing towards the platelet as a true phagocyte (36). Small 
latex particles, taken up in the CS without causing significant 
changes in morphology are observed to localize within dilated, 
vacuolar structures which appear to be altered CS, and not 
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separate "phagosomes". The membranes of these vacuoles retain 
continuity with the cell surface ( 9, 35). Information on the 
mechanism by which platelets sequester latex particles thus 
remains controversial. Various mechanisms have been suggested 
including two separate pathways for endocytosis of large and 
small particles involving the CS and small membrane 
invaginations (11). 
Tracers such as antibodies and cationised f erri tin are 
sequestered from the cell surface into the CS, resulting in a 
cleared surface membrane 
the subject of studies 
substratum (glass). It 
( 10). This clearing phenomenon was 
using platelets spreading on a 
involves a continuous centripetal 
movement of membrane (22,37), with attached markers (such as 
fibrinogen-gold particles) being centralized and sequestered in 
the CS ( 10, 23, 38). The clearing of receptor-ligand complexes 
from the platelet surface membrane to the CS, as 




1.3.2 Endocytic activity in relation to the origin of 
granule proteins 
Certain plasma proteins (e.g. f ibrinogen) found in platelets 
and megakaryocytes have their origin exclusively in the blood 
plasma and no , mRNA coding for f ibrinogen can be detected in 
platelets or megakaryocytes (39). This has led to the 
assumption that the fibrinogen content of secretory granules is 
derived from endocytosis of plasma f ibrinogen ( 39, 40). 
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Megakaryocytes have been suggested to acquire some of their~-
granule proteins (such as IgG, albumin and fibrinogen) from the 
plasma. Distinct mechanisms have been suggested to exist 
within the megakaryocyte for this purpose (32). Proteins may 
be transferred via a coated vesicle route from the cell surface 
to endosomes and then to either lysosomes, Golgi, or secretory 
granules. Other evidence suggests that in addition, ~-granule 
proteins in megakaryocytes may be derived from endogenous 
synthesis via the normal biosynthetic pathway and trafficked to 
the early secretory granule (32). This complex form of 
processing by the maturing megakaryocyte appears to have 
several pathways for processing granule proteins. Platelets 
lack a functional protein synthesis apparatus and are thus 
thought to possess a limited form of the processing pathways 
mentioned above (32). 
Using fluid-phase markers (protein-stabilised colloidal gold 
particles), Behnke (41) has shown structures resembling coated 
pi ts and coated vesicles within mammalian platelets. These 
data propose the possible existence of an endocytic pathway 
responsible for transferring small particulate matter to 
platelet granules. Monoclonal antibodies have also been used to 
characterise endocytosis in resting platelets. Monoclonal 
antibodies against GPIIbIIIa are taken up in an energy 
dependent manner to apparent intracellular vacuoles as 
demonstrated by morphologic analysis. Two models are proposed 
by the author to accommodate the data obtained in this study 
(42; cf. Figure 14). 
10 
1.4 EXPERIMENTAL APPROACH 
As has been discussed, controversy exists as to whether uptake 
occurs by means of endocytosis, or merely involves 
sequestration within the CS. The aim of this study was to 
detect fluid-phase uptake and membrane internalization in 
relation to clearance of antibodies bound to GPIIbIIIa on human 
platelets. 
As a marker for the platelet membrane the exogalactosylation 
technique was used. This technique has previously provided a 
stable membrane marker by way of binding radioactive galactose 
covalently with surf ace glycocon jugates of eukaryotic cells. 
The label can be removed enzymatically with 13-galactosidase 
(43,44). A fluid-phase marker (FITC-dextran) was used to study 
fluid-phase uptake. A monoclonal anti-GPIIbIIIa antibody was 
used to study receptor-ligand internalization with platelets. 
The antibody, designated 3B3, ( 45), was used in conjunction 
with the exogalactosylation technique and along with a 
secondary, fluorochrome-labelled antibody. 
Inununocytochemistry using electron-dense probes was employed in 
an attempt to visualise the precise intracellular compartment 




MATERIALS AND METHODS 
2.1 THE ISOLATION OF HUMAN PLATELETS 
Choice of anticoagulant, as 
protective protein such as 
prevention of activation of 
cell-substratum interaction. 
well as the presence of a 
albumin, is important for the 
platelets due to cell-cell and 
Citrate-citric acid-dextrose is 
commonly used as an anticoagulant due to its calcium chelating 
ability, as well as the effect it has of lowering the pH of the 
blood to 6,5; platelets do not aggregate as readily at this pH 
(50). Contact with glass surfaces is to be avoided as 
platelets are activated by glass. A Tris-containing buffer is 
inhibitory to some platelet functions and should not be used. 
Media similar to those used in tissue culture are preferred 
(5,50), Prostaglandin E1 (PGE1 ) in the medium helps to prevent 
platelet aggregation during manipulation, especially when 
fluctuations in temperature are introduced (24,51). 
Platelets were collected from normal, heal thy donors who had 
not taken any drugs over the previous 10 days that may affect 
platelet function (e.g. aspirin). Collection was done from a 
forearm vein with a 19-gauge winged infusion set using mild 
venous occlusion. Blood was allowed to run into a 50 ml 
polycarbonate tube coated with and containing 8 ml of 
anticoagulant citrate-citric acid-dextrose (CCD) (93 mM 
Trisodium citrate,7 mM citric acid, 140 mM dextrose, pH 6,5, 
with 0,35% BSA, fraction 5) at 37°C. Care was taken to prevent 
frothing of the mixture. 
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The whole blood was spun at low speed (200 x g) in a Beckman 
model TJ-6 benchtop centrifuge at room temperature for 20 
minutes to separate the erythrocytes. Platelet-rich plasma 
( PRP) was removed, taking care to avoid disturbing the white 
blood cell layer, and combined with an equal volume of warm 
CCD. The pH of the PRP was adjusted to 6, 5 by adding O, 2 M 
citric acid. The PRP was centrifuged at 900 x g for 15 minutes 
at room temperature to pellet the platelets. Resuspension of 
the platelets was done using a small-bore pipette with gentle 
action. Platelets were washed twice with prepared Hanks 
Balanced Salt Solution supplemented with 0,1% BSA and 1 µg/ml 
prostaglandin E1 (Sigma) (HBSS P/B), and were counted with a 
Technicon Hl cell counter (Bayer Diagnostics). 
Care was taken with the cells to avoid contact with glass 
surfaces and rapid fluctuations in temperature and pH. 
Platelets prepared in this manner were viable (also after the 
labelling procedures on ice cf below) as shown by their 
susceptibility to activation and spreading if plated onto glass 
coverslips, and observed with the microscope at 1000 x 
magnification (Wild Herbrugg, Switzerland). 
2.2 THE EXOGALACTOSYLATION TECHNIQUE 
2.2.1 Cell-surface labelling 
Platelets were washed twice with 5 ml of HBSS P/B at room 
temperature and cooled on ice. Radioactive galactose was 
covalently linked to terminal N-acetyl glucosamine moieties on 
the platelet surface with galactosyl transferase ( 43, 44) as 
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follows: For a typical volume of 70 µl, the labelling solution 
was made up in HBSS P/B and contained 20 µCi/ml UDP-[ 6-3HJ 
galactose 
MnC1 2 (5 
(ammonium salt, code: TRK 513, 
mM) and galactosyl transferase 
Amersham, England), 
(0,5 u/ml), (from 
bovine milk, code: G-5507, Sigma, USA). 
Typically, 13 0 µl of cells cooled to 4 °C were added to the 
reaction mix, also at 4°C, and mixed. The concentration of 
cells in the reaction mixture was in the order of 1 x 109 
cells/ml ( from 50 ml of blood). The incubation period was 20 
minutes at 4 °C. At the end of this period, the mixture was 
diluted 10-fold and washed four times with cold HBSS P/B. 
2.2.2 Detection of radioactivity 
Cells were solubilised by treatment with O, 5% Triton X-100 
(Sigma, USA) and the tritium was counted using liquid 
scintillation cocktail (Beckman, Palo Al to, California) in a 
Packard 1900 CA scintillation counter (Packard Instruments Inc, 
Canberra). Counting efficiency was about 50%. 
2.2.3 Glycosidase treatment of cell surface 
The glycosidases were in the form of a crude bacterial extract 
and contained 13-galactosidase and neuraminidase activity 
( Thi lo, personal communication). The 13-galactosidase activity 
of the enzyme mixture was determined by monitoring the 
hydrolysis of O-Nitrophenyl-13-D-galactopyranoside (ONPG) (1 
mg/ml) via absorbance at 420 nm (Molar Extinction Coefficient= 
2 f 5) • 
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2 . 2 . 3 ( i ) Pretreatment conditions : In order to improve the 
level of incorporation of galactose into glycoconjugates, the 
cell surface was treated for 10 minutes with glycosidases (0,1 
u/ml fl-gal activity) at 4°C (43), to remove existing terminal 
N-acetyl glucosamine residues. The reaction was stopped by 10-
fold dilution in cold buffer. 
2.2.3 (ii) Removal of cell-surface label: The same glycosidase 
solution ( O, 1 U/ml fl-gal activity) used for pretreatment was 
used to remove label from the cell surface. This was done for 
15 minutes at 4 °C. To quantify release of label, the cell 
suspension with glycosidases was diluted as above, and an 
aliquot removed to measure the total radioactivity per volume. 
The remainder of the suspension was centrifuged at 4 °C to 
pellet the cells, after which an aliquot of equal volume was 
sampled from the supernatant to measure the concentration of 
radioactivity released from the cell surface. The quotient of 
the concentrations of radioactivity in the supernatant and the 
complete cell suspension gave a measure of the fraction of 
label that was released by glycosidase treatment. 
2.3 ANALYSIS OF LABELLED MEMBRANE PROTEINS BY SDS-PAGE 
This was performed according to Maizel 
thick, 25 cm long 5-13% polyacrylamide 
Rainbow protein molecular weight 
International PLC, England) were used. 
(50), using 1,5 mm 
gradient slab gels. 
markers (Amersham 
The proteins were: 
myosin (200 000), phosphorylase b (92 500), Bovine serum 
albumin (69 000), ovalbumin (46 000), carbonic anhydrase 
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(30 000), trypsin inhibitor (21 500) and lysozyme (14 300). 
Alternatively, a mixture of high (MW-SDS-200 Kit, Sigma) and 
low (MW-SDS-70L Kit, Sigma) molecular weight markers were used. 
3H-labelled membrane samples to be analysed on the gel, as well 
as molecular weight markers, were added to equal volumes of 
two-fold concentration sample buffer (10% glycerol, 2,3% SDS, 
5% fl-mercaptoethanol, 0,002% bromophenol blue, 0,042 M Tris-HCl 
pH 6,3) and boiled for one minute. 
Gels were run overnight at a constant 12 mA, and were fixed 
and stained for 30 minutes with a 46% methanol, 8% glacial 
acetic acid, 0,1% Coomassie brilliant blue R mix. Destaining 
overnight in 20% methanol, 8% acetic acid followed. Rehydration 
was with 8% acetic acid, 3% glycerol for 2 hours followed by 
washing in distilled water for 30 minutes before treatment with 
the fluorographic reagent, Amplify (Amersham International PLC, 
UK), for 20 minutes. Gels were then dried in a slab gel drier 
(Model SE 1150, Hoefer Scientific Instruments, San Francisco). 
Alternatively, gels were soaked in 1 M sodium salicylate pH 
7,4, for 30 minutes, after a 30 minute incubation in distilled 
water to remove excess acetic acid, before drying. The dried 
gel was exposed to Kodac XAR-5 film (Sigma Chemicals Company, 
St. Louis, USA) at -70°C to obtain a fluorograph. 
2.4 MEMBRANE INTERNALIZATION ASSAY USING THE 
EXOGALACTOSYLATION TECHNIQUE 
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Labelled cells were incubated in HBSS P/B at 37°C and 75 rpm in 
an orbital shaker bath (TS-611A, Yih Der Instruments, Taiwan). 
Aliquots of about 1 x 108 cells were removed as a function of 
time and diluted in 10-fold volume cold buffer, then placed on 
ice to stop endocytic activity. The cells were then treated 
with glycosidases (0,075 U of fl-Gal/ml) at 4°C for 15 minutes 
in order to remove cell surface label. This fraction of label 
susceptible to release was measured in order to assess the 
amount that had been internalized and was no longer on the 
surface. 
The release of bound radioactivity in the absence of fl-Gal was 
determined from a parallel set of aliquots in order to 
distinguish between the processes of enzymatic label removal by 
fl-gal, and shedding to the medium. 
In a separate experiment, labelled cells were incubated for 3 
hours in HBSS P/B at 37°C and at 4°C. Aliquots of each were 
then treated with or without glycosidases (0,075 U of fl-gal/ml) 
for 15 minutes at 4°C as above. The percentage radioactivity 
released into the medium by fl-gal could then be determined and 
the value obtained with the sample incubated at 4°C could be 
compared with that at 37 °C. This allows the discovery and 
quantification of membrane internalization that may have 
occurred at 37°C. 
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2.5 UPTAKE OF FLUID-PHASE MARKER 
Fluorescein isothiocyanate-dextran (FITC-dextran 40 kD, Sigma) 
was used as a fluid-phase marker. FITC-dextran was made up in 
HBSS P/B. A suspension of platelets in HBSS P/B was added to 
give a final concentration of 109 cells/ml with FITC-dextran at 
10 mg/ml. The suspension was incubated at 37°C for various 
times ( controls incubated at 4 °C) and endocytosis stopped by 
dilution in ice-cold buffer. 
After the incubation period, the cells were washed four times 
in ice-cold buffer, counted, and treated with 0,5% Triton X-100 
for 20 minutes to disrupt all cell membranes. If the mixture 
was cloudy, loose membranes and debris were sedimented in a 
benchtop microfuge at 10 000 rpm for 10 minutes until clear. 
The fluorescence intensity was measured by excitation at 470 nm 
and emission at 520 nm in a Perkin-Elmer LS-5 luminescence 
spectrophotometer. 
An aliquot of the original incubation medium containing the 
fluid-phase marker was diluted a thousandfold, from which 
aliquots of 1 to 5 ml were removed and the fluorescence 
measured. This was used to set up a standard curve indicating 
volume FITC-dextran taken up compared with fluorescence 
intensity. 
2.6 PURIFICATION OF MONOCLONAL ANTIBODY 3B3 
The monoclonal antibody, 3B3, binds exclusively to the human 
fibrinogen receptor, the IIbIIIa glycoprotein complex found on 
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the membranes of human platelets and megakaryocytes. The 
antibody belongs to the murine IgG 1 subclass and was produced 
by fusing spleen cells from Balb/c mice with NS-1 myeloma cells 
using polyethylene glycol (45). 3B3 was a generous gift of the 
Department of Clinical Science and Immunology, UCT. The 
antibody was supplied either as a precipitate from mouse 
ascites fluid stabilized with ammonium sulphate or in a frozen 
PBS-glycerol solution taken directly from hybridoma medium. 
2.6.1 Affinity chromatography 
After desalting, the solution was filtered through a 0,22 µm 
Millex-GS filter (Millipore) before being loaded on a Protein G 
column (Pharmacia LKB), which was first stabilised with 5-10 
column volumes of 20 mM phosphate buffer pH 7. Chromatography 
was performed in a cold room at 4 °C. The column was washed 
with phosphate buffer (20 mM, pH 7) and the bound IgG eluted 
with Glycine-HCl buffer (0,1 M, pH 2,7) into 1 M Tris-HCl, pH 
9, to neutralize the final antibody solution in 1 ml fractions. 
Protein was measured via absorbance at 280 nm (Unicam SP 1800 
spectrophotometer), the relevant fractions pooled and the final 
concentration of protein determined (Molar Extinction 
Coefficient of lmg/ml = 0,69). The pooled solution of IgG was 
supplemented with 0,1% BSA, aliquotted and stored at -20°C. 
2.6.2 Purity analysis by SDS-PAGE 
An ammonium sulphate precipitate of protein from mouse ascites 
fluid containing 3B3, as well as affinity purified 3B3 were 
prepared for SOS-PAGE as described in section 2.3. The samples 
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prepared for SOS-PAGE as described in section 2.3. The samples 
were run on a 5-20% polyacrylamide gel. 
2.7 INDUCTION OF MEMBRANE INTERNALIZATION USING 3B3 
2.7.1 Measurement of internalization using the 
exogalactosylation technique 
Platelets were labelled as described in section 2.2.1 and 
incubated at 37°C in HBSS P/B at 5 x 108 cells/ml (control 
samples were incubated at 4 °C). 
added to a final concentration of 
The antibody 3B3 was then 
2 µg /ml. Parallel samples 
were incubated without 3B3. 
in the orbital shaker. 
Cells were incubated for 3 hours 
The amount of internalized membrane was determined from the 
amount of label released into the medium by glycosidases (0,08 
U/ml B-gal activity) as described in section 2.4. 
2.7.2 Immunofluorescence microscopy 
Immunofluorescent staining of platelets was performed as 
described by Wencel-Drake (42,51) with minor modifications: 
Platelets, suspended in HBSS P/B, and preincubated for 40 
minutes on ice or at 37 °C with 3B3 ( 2 µg/ml) ( control samples 
had no 3B3), were washed and fixed with 3 % paraf ormaldehyde 
(Merck) for 45 minutes on ice. Unreacted aldehyde was blocked 
with 1,5% L-lysine (BDH Chemicals, Poole, England) and the 
cells were washed. 
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To visualise membrane glycoproteins tagged with 3B3 that have 
been interiorized, the cells were then treated with 0,1% Triton 
X-100 for five minutes to render them permeable to the 
secondary antibody. The platelets were then incubated with 
this secondary antibody, a fluorescein-labelled goat F(ab') 2 
anti-mouse IgG ( a gift of the Department of Clinical Science 
and Immunology) for 20 minutes at room temperature. The cells 
were then allowed to adhere to poly-L-lysine coated ( 12 kD, 
Sigma) glass coverslips and washed. The coverslips were 
mounted on mounting medium containing 1 mg/ml 
paraphenylenediamine (Sigma) in a 1:1 mixture of glycerol:PBS. 
Platelets were observed under a fluorescent microscope (Zeiss 
Axioskop: Exciter filter BP 450-490, Barrier filter LP 520) at 
630 x magnification. 
2.8 DETECTION OF LABEL IN THE CANALICULAR SYSTEM BY 
SELECTIVE REMOVAL OF PLASMA MEMBRANE LABEL 
Platelets labelled by exogalactosylation were warmed to 37°C 
for 45 minutes to allow membrane internalization to take place. 
They were then cooled on ice and an aliquot was fixed with 3% 
paraformaldehyde for 45 minutes and washed. Platelets that 
were either at 4°C or fixed were then treated with glycosidases 
(0,1 U/ml B-gal activity) at 4°C for 20 minutes. Label 
released thus, was determined as described in section 2.2.3. 
Platelets were treated as above but in the presence and absence 
of 3B3 in order to determine whether or not incubation with the 
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antibody caused a difference in the amount of label protected 
from glycosidases. 
2.9 PREPARATION OF PLATELETS FOR TRANSMISSION ELECTRON 
MICROSCOPY (TEM) 
Platelets, suspended in HBSS P/B, were fixed with 3% 
paraformaldehyde in White's saline (cf. Table 1) for 30 minutes 
then washed in White's saline before being fixed with 1,25% 
glutaraldehyde in White's saline for 20 minutes ( 5). Cells 
were washed with sodium cacodylate buffer (0,1 M, pH 7,4; with 
5 mM CaC1 2 , 5 mM MgC1 2 ) and post-fixed with 1% osmium tetroxide 
in cacodylate buffer, for 20 minutes. After washing with 
cacodylate buffer, cells were stained with 0,5% tannic acid in 
cacodylate for 5 minutes (52). 
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Before use, mix 5% A, 5% Bin distilled H2o. 
After White JG (5). 
Platelets were washed with cacodylate buffer and resuspended in 
20 µl distilled water. 2% NOBLE agar (cooled to 50°C in a 
water bath, after boiling) was then added to the cells which 
were centrifuged to a pellet in a 50°C water jacket. The tubes 
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were placed on ice for one hour with 70% ethanol covering the 
agar. The agar could then carefully be removed and the 
embedded cell pellet chopped into cubes 1 to 2 mm in size (53). 
The samples were dehydrated in 70%, 90% and 100% ethanol and 
transferred to propylene oxide (Merck). The samples were then 
embedded in EPON-ARALDITE (20% Araldite; TAAB, 27% Agar 100; 
Agar Scientific, 53% DDSA; Bio Rad) resin and polymerized at 
65°C for 48 hours. 
Thin (70 nm) sections were cut onto Cu grids with an 
ultramicrotome (Ultracut E, Reichert-Jung) and contrasted using 
8% uranyl acetate (Merck) and lead citrate. Grids were then 
'washed on drops of distilled water and air dried. Sections 
were viewed under an electron microscope at an accelerating 
voltage of 75 kV (Hitachi H-600 TEM). 
2.10 PRE-EMBEDDING LABELLING WITH GOLD-CONJUGATED 3B3 
2.10.1 Preparation of colloidal gold 
Colloidal gold of 10 nm diameter was prepared according to the 
method of Slot and Geuze (54,55). All glasswear was thoroughly 
cleaned with chromic acid and rinsed with hot water. Briefly, 
a solution of gold chloride (Merck) and a reducing mixture of 
1% citrate, 1% tannic acid and 25 rnM K2co3 were heated to 60°C. 
The reducing mixture was added to the gold solution while 
stirring and boiled for 5 minutes, then allowed to cool. The 
colloidal gold so formed was checked for clumping and 
uniformity of size by mounting on formvar-coated EM grids and 
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viewed under the Hitachi electron microscope at 100 000 x 
magnification with an accelerating voltage of 100 kV. 
2.10.2 Iodination of antibody 
The monoclonal antibody, 3B3, was iodinated by the iodogen tube 
method (56). In an Eppendorf 600 µg 3B3, 2 µl of sodium iodide 
(125I, 100 mCi/ml Arnersham) and 400 µl of Hepes-saline (10 rnM 
HEPES, 140 rnM NaCl pH 7.3) were mixed and then transferred to 
an iodogen tube for 10 minutes on ice. The labelling mix was 
then transferred to Spectrapor dialysis tubing (12-14000 mw cut 
off, SA Scientific products) which was washed three times, each 
for 45 minutes, in saline-EDTA (150 rnM NaCl, 2 rnM EDTA pH 7,4). 
The dialysis bag was 
left to dialyse for 
then placed in 1,5 l of saline-EDTA and 
3 days with daily changes of the wash 
solution. When the free iodine had dialysed out, the dialysate 
was removed from the tubing. Cold 3B3 was added to increase 
the protein concentration which was determined by the method of 
Lowry ( 57). Iodinated protein was counted in a Crystal II 
multidetector RIA-counter (Packard, Canberra) and the specific 
activity determined. 
2.10.3 Conjugation of antibody with colloidal gold 
This was performed according to the method of Geoghegan and 
Ackerman ( 5 8 ) . Adsorption isotherms were determined for the 
irnrnunog lobulin in order to determine the minimum amount of 
protein and optimal pH conditions required for stabilization of 
the colloidal gold. Briefly, protein solutions of different 
concentrations were made up in different pH buffers and mixed 
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with gold colloid solutions at different pH's in a 48-well test 
plate (Falcon, Beckman Dickinson, New Jersey). A solution of 
NaCl was added to a final NaCl concentration of 1,3%, mixed and 
left to stand for 5 minutes and the colour change from red to 
blue assessed, the blue colour indicating that the gold has 
flocculated. The minimum amount of protein required for 
stabilization of the gold is taken from the red coloured well 
with the lowest amount of protein. 
The pH of the colloid was adjusted to 7,5 (from the isotherms) 
with 0,05 M K2co3 and the colloid was centrifuged at 1400 x g 
for 5 minutes in a polycarbonate tube to remove any debris. 80 
µg of antibody was dialysed on a floating polycarbonate 
membrane against distilled water for 1 hour before being added, 
dropwise to the gold colloid while stirring. BSA was added to 
1% and the mixture was centrifuged in polycarbonate tubes at 
25000 rpm at 15°C for 1 hour in an SW 65 Ti rotor (Beckman 
Ultracentrifuge, Palo Alto, California). Supernatant was 
discarded leaving about 10% of initial volume which was 
decanted, leaving particles stuck to the bottom of the tube. 
This was layered on top of a 0,02 M Borate buffer (pH 7,5 with 
1% BSA) with a 90% sucrose solution as a "cushion" at the 
bottom of a polyallomer tube. The tubes were centrifuged at 
25 000 rpm at 15°C for 30 minutes in a SW 40 rotor (Beckman). 
The probe was recovered as a small, mobile, red pellet which 
was washed with Borate buffer (0,02 M, with 1% BSA) pH 7,5 (58-
60) . 
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2.10.4 Binding of gold labelled versus unlabelled antibody 
2.10.4 (i) Radioactivity analysis: The radioactive antibody-
gold probe prepared in section 2 .10. 3 was assessed for its 
binding efficiency to platelets. Platelets were incubated in 
HBSS P/B at room temperature for 90 minutes with either the 
iodinated probe, or iodinated 3B3 that was not conjugated with 
colloidal gold. The cells were then washed with cold HBSS P/B. 
The amount of radioactivity associated with the cells was 
measured after each wash in the gamma counter. 
2 .10. 4 (ii) Immunomarking of platelets: Platelets that were 
treated as described in section 2.10.4 (i) were processed for 
transmission electron microscopy as described in section 2.9. 
2.11 POST-EMBEDDING IMMUNOCYTOCHEMISTRY 
3B3 that had bound to platelets during incubation in suspension 
could be localised in thin sections after fixation and 
processing of the cells for TEM. This technique involves the 
use of secondary or tertiary antibodies to target the antigen 
( in this case 3B3) embedded in the resin of the ul trathin 
sections (47,61). 
2.11.1 Dot Blot analysis 
The immunoreacti vi ty of the antibody probes to be used was 
tested using a nitrocellulose dot blot technique (59,62). 
2.11.1 (i) Rabbit anti-mouse (RAM) with goat anti-rabbit 
(GAR-5): 
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3B3 at two concentrations (0,9 mg/ml and 0,1 mg/ml) were 
applied to two different wells on a nitrocellulose dot blot 
apparatus and allowed to dry. The nitrocellulose membrane was 
removed and incubated in a blocking solution of 5% BSA in Tris-
saline (20 mM Tris, 150 mM NaCl, pH 7,4) on a rocking table 
(Hoefer Scientific Instruments, San Francisco) for 30 minutes. 
The membrane was then incubated with a 1:125 dilution of RAM 
IgG (Janssens Life Sciences Products, Belgium) supplemented 
with 1 % normal goat serum ( a gift from the Department of 
Clinical Science and Immunology, UCT) for 1 hour and washed in 
Tris buffer (20 mM Tris with 0,1% BSA), pH 7,4, for 2 x 10 
minutes. The membrane was then stained with a 1:200 dilution 
of GAR-5 (Janssens) overnight, after which it was washed with 
Tris buffer for 2 x 10 minutes. 
The bound gold was visualised by silver staining according to 
the method of Moermans et al (59). Nitrocellulose strips were 
washed in distilled water and then in citrate buffer (0,2 M, pH 
3,82) after which they were protected from light with foil. A 
developer was prepared (10 ml 2 M citrate pH 4,85; 15 ml 16% 
hydroquinone; 
just prior 
0,7% silver lactate, the components being mixed 
to use) and added to the tube with the 
nitrocellulose for 15 minutes. The product was fixed with 1:10 
diluted photographic fixer ( Ilford) for 2 minutes and washed 
with distilled water before being air dried. 
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2.11.1 (ii) Goat anti-mouse (GAM-10): Serial, double dilutions 
of 3B3 and serial, double dilutions of iodinated 3B3 were added 
to the nitrocellulose and allowed to dry. The nitrocellulose 
membrane was incubated in a blocking soluton of 5% BSA in Tris-
saline (20 mM Tris, 150 mM NaCl, pH 7,4) for 30 minutes. The 
membrane was then incubated with a 1:100 dilution of GAM-10 in 
Tris buffer (20 mM Tris with 0,1% BSA) pH 8,2 for 3 hours. 
After washing, the membrane was treated with the silver 
enhancement stain as described in section 2.11.1 (i). 
The dried nitrocellulose was exposed to Kodac XAR-5 film 
(Sigma) for 3 hours to obtain an autoradiograph. 
2.11.1 (iii) Goat anti-mouse (GAM-10) with whole cells: 
Platelets were incubated for 45 minutes at 37°C with 3B3 at two 
concentrations (0,9 mg/ml and 0,1 mg/ml) in HBSS P/B and washed 
with ice cold buffer. Platelets were then fixed with 2,5% 
glutaraldehyde for 20 minutes and washed. Unreacted aldehyde 
was blocked with 0,6% lysine overnight. Cells were then 
applied to two separate wells on a nitrocellulose dot blot 
apparatus and allowed to dry. The nitrocellulose membrane was 
then treated as described in section 2.11.1 (ii). 
2.11.2 On-grid immunomarking 
Resin blocks containing cells incubated with 3B3 were sectioned 
onto Nickel grids for post-embedding immunocytochemistry. 
These sections were etched with either a 10% solution of sodium 
metaperiodate (Merck) or a 5% solution of hydrogen peroxide for 
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5-7 minutes and washed on drops of distilled water, or jet-
washed with a gentle stream of water from a wash-bottle. 
2.11.2 (i) RAM with GAR-5: Etched sections were treated with 
RAM IgG (with 1% normal goat serum) for 1 hour and jet-washed 
with Tris buffer (20 mM Tris with 0,1% BSA, pH 7,4). The 
sections were then incubated on drops of GAR-5 in Tris buffer 
(20 mM Tris with 0,1% BSA, pH 8,2) for 4 hours and jet washed 
in Tris buffer, pH 7,4. This was followed by fixation with 2% 
glutaraldehyde in sodium cacodylate buffer for 10 minutes and 
washing with distilled water. The sections were contrasted 
using uranyl acetate and lead citrate, washed with distilled 
water, air-dried and viewed under the electron microscope. 
2.11.2 (ii) GAM-10: Etched sections were first blocked with 1% 
normal goat serum in Tris buffer, pH 7,4, and then incubated 
with GAM-10 for 4 hours. Sections were then jet-washed with 
Tris buffer supplemented with 0,1% BSA and fixed with 2% 
glutaraldehyde. After washing with distilled water, sections 
were contrasted with uranyl acetate and lead citrate, washed 
again and viewed under the electron microscope, after being 
air-dried. 
2.12 BIOTINYLATION OF SURFACE MEMBRANE PROTEINS 
Platelets were incubated in HESS P/B contaning 0,5 mg/ml NHS-
SS-Biotin (Pierce) for 1 hour on ice, after which they were 
washed with ice cold HESS P/B. The cells were then incubated 
with iodinated streptavidin (iodinated by the same method used 
for the immunoglobulin, described in section 2.10.2) on ice for 
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30 minutes. Control samples were incubated with non-
biotinylated cells. Platelets were then washed with ice-cold 
HBSS P /B and the cell-associated radioactivity determined at 
each wash. 
At the fourth wash, di thioerythri tol (Merck) was added to a 
concentration of 30 µM, 10-fold the amount needed to fully 
reduce the disulphide bond in the NHS-SS-Biotin (63). After 15 
minutes, the cells were washed and the amount of radioactivity 
removed was counted. 
The biotinylation reaction was also performed with mouse 
macrophages of the P388D1 cell line in a separate experiment 
identical to that described above. DTE as well as B-
mercaptoethanol was used to remove radioactivity bound to the 
cells. 
CHAPTER 3 
RESULTS AND DISCUSSION 
3.1 THE EXOGALACTOSYLATION TECHNIQUE 
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Radioactive galactose (3H-galactose) was introduced onto 
terminal N-acetylglucosamine moieties of surface membrane 
glycoproteins. 
Characterization of membrane interactions and endocytosis with 
platelets in terms of this membrane marker required a series of 
control experiments, namely: 
(i) To apply the membrane marker to cell-surface glycoproteins 
with and without glycosidase pretreatment. 
(ii) To remove the membrane marker efficiently with 
glycosidases. 
(iii) To characterize the molecular composition of the 
labelled glycoprotein species with and without 
glycosidase pretreatment. 
3.1.1 Application of the membrane marker to the cell surface 
In order for this labelling technique to be of any use 
experimentally, the labelling intensity had to be sufficiently 
high to enable quantification of any endocytic activity. The 
amount of label incorporated could be increased by pretreating 
the cell surface with a glycosidase mixture containing 
neuraminidase and 13-galactosidase ( 13-gal) which would remove 
existing, terminal sialic acid and galactose molecules, 
creating more sites for incorporation of radioactivity. 
The optimal labelling conditions had to be established. 




efficiency was tested by measuring the amount of radioactivity 
found in the supernatant after each wash ( Figure 3) . This 
showed that a small amount ( 3-5%) of label was repeatedly 
removed by each wash. This probably relates to label 
associated with the membranes of cells disrupted during 
resuspension of the platelets with the pipette, as well as 
label trapped in crevices or channels of the cells. 
The effect of different concentrations of Mn2+ in the labelling 
mixture can be seen in Figure 4. Labelling intensity proved to 
be highest at a Mn2+ concentration of 5 mM, the concentration 
at which subsequent labelling was conducted. At concentrations 
below 5 mM MnC1 2 , manganese ions were the rate-limiting factor 
to labelling. At concentrations above 5 mM, no increase in 
labelling intensity was detected up to 15 mM, a concentration 
above which Mn2+ may be toxic to the platelets. 
Two buffers were assessed for their suitability as labelling 
media: Hepes-saline (10 mM Hepes, 150 mM 
supplemented with 0,1% BSA and 1 µg/ml PGE1 , 
NaCl, pH 7, 4) 
and HBSS P /B. 
This was also done to assess whether or not the phosphate ions 
in the HBSS were complexing with the manganese ions in the 
labelling mix, leading to the formation of insoluble manganese 
phosphate. This would effectively remove the Mn2+ from 
solution with a consequent lowering of labelling intensity. 
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Fig. 1. Schematic diagram summarizing structures observed in 
discoid platelets. 
A number of ultrastructural features may be observed in cross-
sections of platelets. The cells have a trilaminar plasma 
membrane (PM) and may exhibit the circumferential band of 




of circulating blood platelets. Glycogen 
are usually centralized. Organelles such as 
and remnants of Golgi vesicles may also be 
seen, as well as ~-granules (G) and granules containing dense 
bodies ( G + DB) . Membrane systems include the dense tubular 
system (DTS) which serves as the platelet sarcoplasmic 
reticulum, and the canalicular system (CS). The canalicular 
system may either appear as membrane-bound vesicles or as 



















Fig 2. Kinetics of cell-surface labelling with radioactive 
galactose. 
Platelets were incubated with galactosyltransferase and 
radioactive UDP-galactose for 20 minutes on ice (a). A 
parallel sample was incubated for 20 minutes without 
galactosyltransferase (D), Aliquots (of about 25 x 106 cells) 
were removed at various times and diluted in cold buffer to 
stop the reaction. Platelets were then washed and cell-
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Fig. 3. Post-labelling washing efficiency. 
Platelets were labelled as described in Figure 2. At each wash 
step, the amount of radioactivity in an aliquot of supernatant 
after centrifugation was determined, and expressed as a 
percentage of an equal volume aliquot of cell suspension (about 
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Fig. 4. Effect of Mn2+ concentration on labelling intensity. 
Platelets were resuspended in Hepes-saline (•) or Hanks 
Balanced Salt Solution ( •) and cooled on ice. Platelets were 
then labelled, as described in Figure 2, in aliquots (of about 
1 x 108 cells) containing increasing concentrations of Mn2+. 
After washing with cold buffer, cell-associated radioactivity 
was quantified. Arrow represents concentration of Mn2+ used in 
subsequent experiments, unless otherwise stated. 
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5 mM MnC1 2 . HBSS P/B was used as the buffer of choice due to 
its suitability as a medium for platelets (5). 
Following pretreatment of the cells with glycosidases for 10 
minutes, the labeling intensity was increased by as much as 10-
fold (Figure 5). 
Discussion 
The pretreatment of platelets was not employed for subsequent 
experiments, even though the significant increase in cell 
surface label would be preferable from a quantification point 
of view. It was considered preferable to subject the cells to 
as few manipulations as possible. Also, after pretreatment of 
the cells and subsequent labelling, platelets became difficult 
to resuspend and tended to form small aggregates, making 
accurate counting of cell numbers in the Hl counter difficult. 
Al though the labelling 
were preincuba ted with 
the amount of label 
pretreatment was still 
intensity was greater when 
glycosidases (approximately 
associated with the cells 
sufficient (200-400 DPM/106 
platelets 
10-f old) , 
without 
cells) . 
Also, the increase in labelling intensity had to be weighed 
against the extra manipulations to which the cells were 
subjected. The labelling intensity also tended to vary with 
platelets from different donors. The molecular basis for this 
difference is not known but care was taken to perform any 




















































Fig. 5. Effect of pre-treatment with neuraminidase and fl-
galactosidase on the platelet surface labelling intensity. 
Platelets were either labelled as described in Figure 2 (e) or 
pre-treated with fl-Gal (0.1 unit/ml) for 10 minutes in the cold 
before labelling ( •). Aliquots of about 1 x 108 cells were 
removed as a function of time and the cell-associated 
radioactivity determined. 
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3.1.2 Removal of label with qlycosidases 
Figure 6 shows the kinetics of label removal from the cell 
surface by glycosidases. After 20 minutes treatment with 
glycosidases on ice, 95% of label could be removed. After 120 
minutes, 4-5% of the label remained resistant to glycosidase 
removal. 
Discussion 
Efficient removal of surface label was essential to subsequent 
experiments involving endocytosis studies. A concentration of 
B-gal of between O, 07 5 and O, l U/ml was employed to remove 
surface label. An amount of label appeared to be released from 
the cells in the absence of glycosidase treatment. Whether 
this related to label from disrupted cells, label remaining in 
cell crevices and channels or label actively II shed II from the 
platelets, was uncertain. In subsequent experiments, the 
amount of label released in the absence of B-gal was taken into 
account when determining the label actually removed by direct 
enzymatic action of the glycosidases. This label was commonly 
in the order of 5-15%, more being released at 37°C than at 4°C. 
A time of 20 minutes was employed for pretreatment of the cells 
with glycosidases, as well as for the use of glycosidases to 
remove bound label. From Figure 6 it can be seen that a 
significantly larger amount of label cannot be released with 
longer treatment of glycosidases. Also, prolonged incubation 
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Fig. 6. Removal of cell-surface label by B-galactosidase. 
Platelets were labelled as described in Figure 2. Platelets 
were then treated with .B-galactosidase at 0.075 units/ml on 
ice. Aliquots were then removed into cold buffer and the 
radioactivity determined. After centrifugation, radioactivity 
of supernatant was measured in order to determine the fraction 
of label released. Symbols (a) represent the results of two 
separate experiments. Arrow represents the amount of label 
released in the absence of .B-gal as averaged from results in 
separate experiments (Figures 7,8,9), s = 4,0. 
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platelets tended to form small aggregates that were difficult 
to resuspend and caused a decrease in the counting efficiency 
with respect to cell number. 
There appeared to be a fairly high variation in the amount of 
label shed from the platelets in the absence of glycosidase 
treatment. At 4°C, label shed was about 10%. Cells at 37°C 
tended to shed label at a level about 10-11% higher. The cause 
of this apparent "shedding" of label is not known but a similar 
phenomenon is known to occur with other cell types (64, and N. 
Godenir, personal communication) and is thought, in part, to 
result from an active process. The shedding could include 
unbound label escaping from the canalicular system channels 
where the effects of washing of the platelets could be slowed 
down by diffusion. 
This shed label was either determined in separate samples of 
each subsequent experiment and subtracted from the amount of 
label removed by glycosidases, or the platelets were washed 
prior to their treatment with glycosidases, to eliminate the 
effect of shedding. 
3.1.3 Analysis of the molecular weight composition of platelet 
membranes as labelled by the exogalactosylation technique 
The platelet cell surface was labelled with and without 
pretreatment with glycosidases as described in Figure 5. The 
composition of labelled molecular species was analysed by SDS-
PAGE. Figure 7 shows that the degree of labelling of the cells 
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Fig. 7. Fluorography of radiolabelled platelet membranes. 
Platelets were treated as described in Figure 5. In addition, 
aliquots of pre-treated and non pre-treated cells were labelled 
at 37°C. Platelets were prepared for electrophoresis under 
reducing conditions in a 5-13% polyacrylamide gel. The dried 
gel was processed for fluorography and exposed at -70°C for 8 
days (pre-treated cells) and for 34 days (non pre-treated 
cells) . 
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pretreated with glycosidases was much greater. The number of 
molecular species radiolabelled by the pretreatment method was 
greater than that labelled without pretreatment. Cells 
labelled at 4°C show no difference in the degree of labelling, 
or in the number of labelled species relative to cells labelled 
at 37°C. 
Discussion 
Of interest was the observation that labelling the cells at 
37°C had no effect on the labelling intensity or on the number 
of Mr species labelled. After 20 minutes, little increase in 
labelling intensity occurred. That there was little or no 
difference in the number of labelled species after labelling at 
3 7 °C has some interesting implications. At 3 7 °C, the cells 
would be expected to endocytose some of the labelling mixture, 
possibly causing intracellular membranes of the endocytic 
pathway to become labelled. This would, in turn, conceivably 
label molecular species not present on the cell surface and 
alter the composition of the labelling profile as seen in 
Figure 7. This did not occur. Whether this would happen with 
other cell types known to have an active endocytic mechanism at 
37°C, can only be speculated upon. 
3.2 CHARACTERIZATION OF CONSTITUTIVE ENDOCYTIC ACTIVITY 
The exogalactosylation technique (43), as described in section 
3.1, was used to determine the existence of constitutive 
endocytic activity of resting human platelets. Endocytosis 
implies that internalization of membranes takes place during 
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coated pit and endosome formation. This would imply that 
labelled components of the plasma membrane are redistributed to 
internal sites of the cell. These sites would be inaccessible 
to the glycosidases employed to remove this label as the 
enzymes are presumably unable to traverse the cell membrane 
bilayer. There is thus reduction in the amount of label 
removed after glycosidase treatment. This should fallow a 
time-dependent course as more membrane is internalized. 
Complementing membrane internalization analysis, uptake of 
fluid-phase components was also characterized with platelets in 
the resting state. When endosomes are formed at the plasma 
membrane, part of the surrounding medium of the cells is taken 
up and traverses the lumen of the endocytic pathway. 
be analysed with the use of fluid-phase markers. 
This can 
3.2.1 The use of the exogalactosylation technique to measure 
labelled membrane uptake with resting cells 
After labelling the platelets at 4°C as described previously, 
they were warmed to 37 °C and incubated in buffer. Figure 8 
(bars) was expected to indicate a time-dependent decrease in 
amount of label accessible to removal by glycosidases from the 
cell surface. No such decrease was observed. This indicates 
that over 20 minutes, there was no perceived endocytosis of 
membrane. An average of 75% of label was removed by B-gal. 
In the event that endocytic activity was a very slow process 
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Fig. 8. Label accessible to removal by B-galactosidase, after 
incubation of platelets at 37°C. 
Platelets were labelled as described in Figure 2. After 
warming to 37 °C, aliquots were removed as a function of time 
and cooled on ice to stop endocytosis. In order to remove 
surface bound (accessible) label, cells were incubated with fl-
gal in the cold, and the amount of label released was measured 
(•)· In addition, platelets were incubated without fl-gal, in 
the cold, and the amount of label released was measured (D). 
The values represented by open symbols were subtracted from 
those with closed symbols to give the amount of label released 
by fl-gal (represented by bars). 
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Fig. 9. Determination of membrane internalization: removal of 
surface-bound label by fl-galactosidase, after incubation at 4°C 
and 37°C for 3 hours. 
Platelets were labelled as described in Figure 2 and incubated 
for 3 hours at 4 °C or at 37 °C. Aliquots from each were then 
treated with B-galactosidase in the cold to remove accessible 
label. The percentage label released was determined by 
centrifugation as described in Figure 4. Percentage label 
"shed" from cells without fl-gal treatment was subtracted from 
percentage label released by fl-gal. The final value obtained 
is expressed with error bars representing the standard 
deviation of 12 samples (three separate experiments). 
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hours at 37°C. As shown in Figure 9, after 3 hours at 4°C, 
about 76% of label (s = 7%) was removed. With cells at 37°C, 
71% of label (s = 5%) was removed. Although the mean was less 
with the cells at 37 °, there was no statistical significance 
between the values as seen by the standard deviation of the 
mean. 
Discussion 
No significant difference between label accessible to 
glycosidase release was detected between cells incubated at 
4°C, and cells incubated at 37°C. Even a low endocytic rate 
should have been detected after 3 hours using this technique 
( 44) . 
By looking at the number and intensity of molecular species 
labelled using the exogalactosylation technique at 4°C, as seen 
in Figure 7, it is possible that endocytosis may involve the 
internalization of membrane species that were either labelled 
poorly, or not at all. This leaves the possibility that 
endocytosis could be observed after first pretreating the cells 
with glycosidases, to increase the number of labelled species 












3.2.2 Uptake of fluid-phase marker as a measurement of 
endocytic activity with resting cells 
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Because no membrane internalization could be measured by the 
exogalactosylation technique, a fluid-phase uptake assay was 
employed. FITC-dextran was used as the fluid-phase marker 
( 6 5) . 
Uptake of FITC-dextran (10 mg/ml) at 4°C versus 37°C is shown 
in Figure 10. Curves indicated a very low apparent rate of 
uptake (1,8 fl/106 cells/min). The rate of uptake of FITC-
dextran at 4°C was only marginally lower than that at 37°C 
(0,47 fl/106 cells/min lower). In Figure 10, the 4°C curve is 
shown by the broken line. 
Discussion 
Even in relation to the small volume of the platelet (mean cell 
volume= 5,2 - 7,7 fl) the rate of endocytic volume uptake was 
negligibly small when compared to the rates of endocytosis of 
other cell types (Table II). These results confirmed the 
findings that membrane internalization could not be detected by 
the exogalactosylation experiments. 
It would thus appear that if endocytosis with resting platelets 
was occurring, in a basal or constitutive form, the rate of the 
process is extremely low. Such a slow process would appear to 
have little physiological function. Many workers have 
discussed circulating platelets as endocytic cells (9-14) but 
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Fig. 10. Fluid-phase uptake assay by platelets. 
Platelets were incubated with the fluid-phase marker, FITC-
dextran at 4°C (o), and at 37°C •).Aliquots were removed, as 
a function of time, into cold buffer to stop endocytosis. 
Platelets were then washed, counted, and treated with Triton X-
100. Membrane debris was sedimented and fluorescence intensity 
measured on a fluorimeter. Error bars show an average of two 
samples. Concentration of FITC-dextran used in the incubation 
was 10 mg/ml. (•): Slope= 1.85 fl/106 cells/min. (o): Slope= 
1.38 fl/106 cells/min. 
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Table II. Kinetic data on pinocytic rates 
V, volume; 
rate. 
S, surface area; d, diameter; v, volume uptake 
Cell type Cell dimensions Internalization 
Mouse peritoneal macrophages 395 825 9,1 
Mouse macrophage cell line, 
J774 1662 3925 14,7 
Guinea-pig alveolar 
macrophages 1750 2250 15 
Mouse macrophage cell line, 
P388D1 900 1300 12 
Mouse fibroblasts, L cells 1765 2100 15 
Human fetal lung fibroblasts 
IMR-90 2500 2670 16,8 
*Human platelets 6,5 22,2 3,6x0,9 
From Thilo L. (44) 









3.3. THE USE OF A MONOCLONAL ANTIBODY TO INDUCE MEMBRANE 
INTERNALIZATION 
It had been reported previously that antibodies to the 
fibrinogen receptor of human platelets, the so-called GPIIbIIIa 
complex, are internalized in a time-dependent fashion. Also, 
this internalization required active metabolic function and did 
not occur at 4°C (42). Antibodies against other membrane 
glycoproteins (i.e. GPib) were not internalized (24). Several 
different monoclonal and polyclonal antibodies to GPIIbIIIa 
were used with apparently identical results (42). 
so 
The monoclonal antibody against GPIIbIIIa, designated 3B3 (45), 
was used in this study to observe if specific internalization 
of this receptor complex occurred using the exogalactosylation 
technique. Assuming the 3B3 binding elicited the same effect 
as antibodies used in previous studies, the internalization 
process should become detectable. It was thus necessary to: 
(i) purify the monoclonal antibody 
(ii) determine whether 3B3 was indeed binding to the platelets 
under the experimental conditions used and whether 
redistribution occurred in the same way as for other 
antibodies reported in previous studies. 
(iii) measure whether the presence of 3B3 caused stimulated 
internalization of labelled membrane. 
3.3.1 Purification of the antibody and analysis of purity 
The monoclonal antibody, 3B3, was purified by affinity 
chromatography on a protein G column. The purity was assessed 
by analysis on an SDS polyacrylamide gel (Figure 11). 
3B3-rich mouse ascites fluid was harvested and pooled and the 
proteins precipitated with ammonium sulphate. The molecular 
weight composition of reduced proteins from the IgG-rich 
fraction is shown in lane 2 of the gel in Figure 11. The IgG 
heavy chains of 50 000 D as well as light chains of about 
24 000 D appear. Several bands appear in addition to the IgG 
chains including a large band in the region of 66 000 D. 
is the albumin present in the mixture. Lane 1 shows 
This 
the 
composition of proteins from the pooled fractions eluted off 
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the column and shows only the IgG chains present. A very faint 
band in the 66 000 region reflects a small amount of albumin. 
3.3.2 Stimulated internalization of labelled membrane by 
platelets incubated with monoclonal antibody 
The exogalactosylation technique was used in an attempt to 
measure endocytosis of labelled membrane after the antibody 3B3 
was added to a suspension of cells and warmed to 37°C. Figure 
12 indicates the amount of membrane accessible to removal by 
glycosidases. 76,5% (s = 5,5) and 75,5% (s = 4,5) of label was 
removed after the 4°C and 37°C incubation, 
the presence of 3B3, 74% (s = 4,0) and 72% 
respectively. In 
(s = 5,0) of label 
was removed after the 4 °C and 37 °C incubation, respectively. 
The differences between these values were not statistically 
significant. 
Discussion 
It would appear that even in the presence of antibody to the 
receptor complex GPI IbI I Ia, no detectable endocytic activity 
took place. This is contrary to expectations and differs from 
previous studies that claim to show internalization of the 
receptor-antibody complex (24,42). 
3.3.3 An immunofluorescence technique to localise internalized 
receptor-antibody complex 
An immunofluorescence study was employed to test the binding of 
the antibody to the cells (i.e. whether or not the 3B3 in fact 
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Fig. 11. Purity analysis by SDS-PAGE, of affinity purified 
The monoclonal anti-human GPIIbIIIa IgG, 3B3, was raised in 
mice and affinity purified on a protein G column as described 
in the Methods. The purity of the antibody was analysed on a 
5-20% polyacrylamide gel under reducing conditions and stained 
with coomassie blue. 
lane 1 of the gel. 
The purified antibody was loaded onto 
An ammonium sulphate precipitate of the 
antibody from ascites fluid (prior to affinity chromatography) 


























Fig. 12. Membrane internalization in the presence and absence 
of monoclonal antibody, 3B3. 
Platelets were labelled as described in Figure 2 and cooled on 
ice, or warmed to 37 °C. Platelets were then incubated in the 
presence and absence of anti-GPIIbIIIa antibody, 3B3 for 3 
hours. Subsequently, B-galactosidase was used to remove 
surface-bound label. The fraction of removed radioactivity was 
calculated as described in Figure 4. Values shown were 
corrected for label shed into the medium during the 3 hour 
incubation. Error bars represent the standard deviation of 
four samples from two separate experiments. 
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recognised the GPIIbIIIa). It could also be used to determine 
if internalization of the antibody took place and if this 
process was temperature dependent. The experimental approach 
was essentially the same as that described by Wencel-Drake et 
al. (42,51). The results are summarized in Figure 13. 
Platelets incubated with 3B3 and then stained with goat anti-
mouse IgG-F(ab') 2-FITC showed a bright green fluorescent 
pattern. Controls (not shown) treated in the same way but in 
the absence of 3B3 showed only a background fluorescence 
attributable to autofluorescence of the paraformaldehyde (this 
was of a more yellow-green colour) and very low levels of non-
specific binding of the fluorochrome-IgG. The controls are not 
shown as the automatic camera could not be used to take 
micrographs of such low-light images at the same exposure as 
the micrographs of fluorescing platelets. These results 
indicated that the 3B3 was indeed binding to the platelets and 
could be visualised with the fluorescent secondary antibody. 
Platelets not perrneabilised with Triton X-100 prior to staining 
with secondary antibody showed a rim-pattern fluorescence 
(Figure 13B, - TX 100) indicating antibody bound to the surface 
of the cell. The permeabilised cells ( Figure 13B, + TX 100) 
showed, in addition, fluorescent areas within the cell 
indicating that the 3B3 had been internalized. Platelets 
labelled with 3B3 in the cold and perrneabilised before staining 
showed a rim-pattern fluorescence. Uptake of 3B3 thus appeared 
to be an active metabolic process. 
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Fig. 13. Immunofluorescence microscopy of platelets incubated 
with 3B3. 
Platelets were incubated for 40 minutes in the presence (A;B) 
and absence (not shown) of 3B3, on ice (A) and at 37°C (B). 
Platelets were then fixed with 3% paraformaldehyde on ice for 
45 minutes. Aliquots of A and B were rendered permeable by 
brief (5 minutes) treatment with Triton X-100 (indicated in the 
figure as +TX-100). Permeabilised and non-permeabilised 
platelets were then incubated for 20 minutes with goat anti-
mouse IgG-F (ab' ) 2-FITC, at room temperature. Platelets were 
then allowed to adhere to poly-L-lysine coated coverslips and 
observed under the fluorescence microscope at 630 x 
magnification. Platelets incubated in the absence of 3B3 
exhibited low levels of non-specific, background fluorescence 
(micrographs not shown - see Results). 
Both permeabilised and non-permeabilised platelets incubated 
with 3B3 at 37°C are shown (B: ± TX-100). Only permeabilised 
cells incubated with 3B3 at 4°C are shown (A). Two panels of 
each treatment are shown to provide a larger field of view. As 
in any one field only some cells will be in the correct plane 
of focus, arrows indicate particularly clear examples. 
A rim-pattern fluorescence can clearly be seen with the 
platelets incubated on ice (A), as well as with those incubated 
at 37°C without subsequent permeabilisation (B: -TX-100). 
Interior staining can be seen in the platelets incubated at 
37°C and followed by permeabilisation, before staining. 
A 
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Discussion 
The results are essentially the same 
other antibodies by Wencel-Drake (42). 
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as those reported for 
The 3B3 was recognising 
GPIIbIIIa on the platelet membrane, binding to it and was being 
redistributed to sites within the cell in a process requiring a 
functional cell metabolism. 
Only after treatment with Triton, was internalized 3B3 
accessible to staining with secondary antibody. This may lead 
to the deduction that the 3B3 had been transferred to an 
intracellular, membrane-bound site such as an endosome or 
l ysosome, i.e . 
exogalactosylation 








in Figure 12 
This apparent 
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anomaly can be explained if the possibility is taken into 
account that the 3B3 has not been endocytosed but sequestered 
in the canalicular system. This possible mechanism would 
provide for the clearing of particulate matter from the 
platelet surface, as reported in other studies (10,29,34,37). 
For the sake of discussion, the term interiorized (rather than 
internalized, which implies true endocytosis via coated 
vesicles etc) is used to describe the fate of the 3B3 bound to 
the platelet surface receptors. 
Two models were proposed to accommodate the data discussed by 
earlier workers. These models are summarized in Figure 14 
( 42). Previous authors were apparently unable to use either 
model A or model B to fully accommodate data. The present 
study gave evidence for model B Figures 12 and 13). An 
anomaly that still persisted was that if sequestration into the 
canalicular system had occurred, why was anti-GPIIbIIIa 
antibody in both the Wencel-Drake study and the present study 
only accessible to staining with secondary antibody after 
Triton treatment, as the canalicular system is in continuity 
with the platelet's surrounding medium? The finding that the 
antibody was transferred to an intracellular compartment 
accessible only after permeabilisation, has been used as the 
evidence for model A in Figure 14 (42). It was thus necessary 
to discover whether fixation with paraformaldehyde prevented 
entry of molecules such as enzymes and antibodies (e.g. fl-gal 
and secondary antibody - FITC conjugates) to the canalicular 
system. This would provide evidence for model B and account 




Fig. 14. Models for internalization of receptor-ligand complex 
GPIIbIIIa-3B3. 
Two model systems are illustrated. In Model A, labelled 
GPIIbIIIa (open circles) is actively endocytosed into vesicles 
which may be transferred to the canalicular system, granules or 
back to the plasma membrane. Alternatively, in Model B, 
labelled GPIIbIIIa (open circles) is cleared from the surface 
by an active mechanism and sequestered in the canalicular 
system, which in thin section, at the electron microscope 
level, or at the level of resolution of the light microscope 
would appear vesicular in nature. (Wencel-Drake 1990). 
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3.3.4 Measuring canalicular system label protected from 
glycosidases by fixation 
Platelets labelled using the exogalactosylation technique as 
before were treated with 3B3. Cells were cooled and either 
fixed with paraformaldehyde or maintained at 4°C on ice. 
Results are shown in Figure 15. After treatment with 
glycosidases, 77% of label was removed with the cells on ice (a 
value in agreement with data in Figure 12). Only 55% of label 
was removed after the cells were fixed. 
22% of label was glycosidase resistant. 
Thus, after fixation, 
It is unlikely that 
this was due to the fixation preventing removal of cell-surface 
material as such. It has been shown, for macrophages, not to 
be the case ( 45) . The exogalactosylation labels only the 
terminal ends of glycoprotein moieties, a molecular region not 
normally affected by paraformaldehyde. 
An attempt was made to detect any differences in the amount of 
label retained in the canalicular system after treatment with 
and without 3B3. If the 3B3 was being sequestered in the 
canalicular system, the possibility existed that this would 
alter the fraction of the glycosidase-resistant label. Figure 
16 indicates little difference (26% protected in the absence of 
3B3, 25% protected after incubation with 3B3). 
Discussion 
From Figure 15 
para formaldehyde 
and Figure 16 it can be deduced that 


















Fig. 15. Label removal by fl-galactosidase with fixed and 
unfixed platelets. 
Platelets were labelled as described in Figure 1. Platelets 
were then incubated for 45 minutes at 37°C, in the presence of 
3B3, after which they were cooled to 4°C. An aliquot was then 
fixed with 3% paraformaldehyde for 45 minutes. Platelets were 
then treated with B-galactosidase in the cold, to selectively 
remove label bound on the surface of the cell, and not label in 
the canalicular system. 
described in Figure 4. 

























Fig. 16. Degree of label protected from B-galactosidase removal 
when platelets are fixed: after incubation with and without 
Platelets were labelled and incubated as described in Figure 
12, in the presence and absence of 3B3. The amount of label 
associated with the membranes of the canalicular system 
(measured as amount of label fixation-protected from B-gal) can 
then be compared. 
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membranes of the canalicular system protected from enzymatic 
removal by glycosidases. With platelets cooled to 4°C, 
glycosidases are most likely able to diffuse into the channels 
and remove the label. This is shown by the findings in Figure 
13. The fixed platelets show interior staining only after 
permeabilization. This is not because the 3B3 has been 
internalized (or endocytosed) but more likely because the 
staining antibody does not have access. Thus, the terms 
surface bound, and accessible do not necessarily refer to the 
same label. Surface-bound label refers to label on the plasma 
membrane of the platelet, while accessible label refers to 
label that is capable of removal with glycosidases. 
3.4 ELECTRON MICROSCOPY AND IMMUNOCYTOCHEMISTRY 
In order to visualise the intracellular compartment into which 
the 3B3 was transferred following its binding to platelet 
membrane GPIIbIIIa, it became necessary to observe the platelet 
ultrastructure at the electron microscope level. At the 
magnification possible it was hoped to provide further evidence 
that the interiorized 3B3 was in fact being sequestered in the 
canalicular system. If this could be demonstrated, it would 
strengthen the Model B hypothesis of Figure 14. Several 
workers have demonstrated immunocytochemical staining of 
antibodies and receptors, both internalized and on the platelet 
surface with cells embedded in conventional hydrophobic and 
hydrophilic resins as well as cryosections (10,17,40,42,46). 
To achieve this with the system and antibodies used in the 
present study it was necessary to: 
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(i) prepare human platelets for electron microscopy with clear 
ultrastructural detail especially with respect to 
cellular membranes 
(ii) develop a system whereby an electron-dense immunogold 
probe could be used to target intracellular 3B3, either 
by labelling of the 3B3 itself, or application of a 
secondary or tertiary antibody system. Procedures using 
pre-embedding labelling as well as post-embedding 
labelling were established. 
3.4.1 Preparation of platelets for electron microscopy and 
morphological assessment 
Platelets were prepared as described in Materials and Methods. 
Results are shown in Figure 17. From the figure, the platelets 
exhibit many of their ultrastructural features. The membranes 
are clearly marked with the staining methods used. The buffers 
used in the preparation of the platelets were chosen for their 
suitability for the preservation of ultrastructural detail (5). 
Platelets were also fixed in suspension rather than as a 
pellet, after centrifugation. It has been demonstrated that 
the close cell contact in the pellet partially activated 
platelets and caused shape changes during fixation (5). Sodium 
cacodylate was used to buffer the osmium tetroxide during 
postfixation as it was found to have a beneficial effect of 
preserving internal membrane structures. Staining with tannic 
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uniformly as 
the amount of 
acid staining did not mark the 
expected, possibly due to the 
membrane in the thin sections. 
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Depending on the orientation and aspect of the canalicular 
system membranes, some show more membrane area in the section 
and thus appear darker. Post-fixation with osmium tetroxide 
generally led to clearer membrane staining and higher contrast 
(Figure 17C,E). 
Discussion 
The protocol for electron microscopy of platelets was able to 
demonstrate ultrastructural morphology of the cells especially 
with respect to cell membranes and membranes of the canalicular 
system. The micrographs indicate the ramifying and extensive 
nature of the platelet canalicular system as well as its degree 
of morphological variation both in longitudinal and cross-
section. Postfixation with osmium tetroxide as well as 
staining with tannic acid enhanced the clarity of the internal 
membrane structures, even the thin, finer membranes of the 
canalicular system. These membranes generally stained with a 
lower intensity than the plasma membrane and also appeared 
slightly thinner. 
3.4.2 Radioactivity analysis of binding of gold-labelled 3B3 
Colloidal gold with an average particle diameter of 10 nm was 
prepared as described in the Methods. At 100 000 x 
magnification under the transmission electron microscope, the 
gold was observed to be in the form of monodisperse, electron-
dense particles of uniform diameter (results not shown). 
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A B 
Fig. 17. Electron microscopy (TEM) of platelets for 
morphological assessment. 
Platelets were incubated in HBSS P/B in the presence of 3B3 and 
prepared for electron microscopy as described in the Methods 
section. Most of the components of the conventional morphology 
of platelets can be seen: plasma membrane, membranes of the 
canalicular system, granules and dense bodies. 
A,B Longitudinal section of resting platelets (G) ~-granules, 
(CS) canalicular system, (G+DB) granule containing dense body. 
Mag. = 30 000 x. Postfixation with osmium tetroxide. 
C Cross or transverse section of a platelet prepared with 
postfixation in osmium tetroxide to enhance membrane staining. 
Mag= 25 000 x. 
D Cross or transverse section without osmium tetroxide 
postfixation. Mag= 20 000 x. 
E Langi tudinal section at 
postfixation showing marked 
membranes. Mag= 50 000 x. 
high magnification with 
staining of canalicular 
osmium 
system 
F Longitudinal section at high magnification without osmium 





Iodination of 3B3 yielded a protein with a specific activity of 
34 x 103 cpm/µg. After conjugation of 3B3 with colloidal gold, 
a theoretical specific activity of 4,5 x 103 cpm/µg protein was 
estimated based on the starting concentration of protein 
(protein determination after conjugation of gold was not 
performed; 
higher). 
actual specific activity was probably somewhat 
Figure 18 shows the binding of the 3B3-gold conjugate in 
relation to the unconjugated 3B3. The conjugate bound to the 
platelets only slightly less efficiently than the unconjugated 
antibody. 
3.4.3 Localization of the interiorized receptor-antibody 
complex using a pre-embedding technique 
An attempt was made to visualise the gold-conjugated 3B3 bound 
to the platelets. The cells were labelled as in section 3.4.2 
and the binding analysed as in Figure 19. Platelets were then 
processed for TEM as described in the Methods. The amount of 
radioactivity in the cell pellet contained in the resin blocks 
just prior to sectioning was analysed to ascertain if bound 
antibody was still present after the processing and embedding. 
This was found to be the case (Figure 19). The block was then 
sectioned for TEM. 
Figure 20 shows micrographs of sectioned platelets stained with 
3B3-gold. No gold particles could be seen in any of the 
micrographs. The pellet was sectioned several times and serial 
sections were observed to a total thickness of about 1, 5 µm, 
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without visualisation of gold staining. Morphological analysis 
showed resting platelets with distended canalicular system 
structures (Figure 20). An opening to part of the canalicular 
system of one of the platelets can be seen as indicated by the 
large arrow in Figure 20. 
Discussion 
The micrographs in Figure 20 demonstrate that no gold was seen. 
Although this would indicate that binding of 3B3-gold did not 
occur, the radioactivity present, reflected in Figure 19, 
showed that the probe was present in the tissue. There are two 
possible explanations for this discrepancy. Firstly, it may be 
that the sections observed were from a part of the pellet that 
contained cells with few bound probes due to the binding being 
less than was previously thought. This is unlikely because a 
depth of 1, 5 µm was scanned in the serial sections without 
noting any probes. Also, from the amount of radioactivity 
present in the tissue, the amount of probe was high. Secondly, 
it may be that the radioactive 3B3 is binding, but the gold 
either failed to conjugate properly with the antibody, or 
simply detached from it during manipulations. This is feasible 
as conjugation of gold with another monoclonal antibody was 
proved to be unsuccessful due to gold failing to bind. 
3.4.4 Localization of the internalized receptor-antibody 
complex using a post-embedding technique 
The pre-embedding technique employed in section 3.4.3 was 
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Fig. 18. Binding of 3B3 versus binding of gold-labelled 3B3. 
Platelets were incubated at room temperature for 90 minutes 
with either iodinated 3B3 (hatched bars), or iodinated 3B3 
conjugated with 10 nm gold (open bars). Efficiency of washing 
as well as the amount of cell-associated radioactivity was 
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Fig. 19. Binding of 3B3 versus binding of gold-labelled 3B3: 
processing for electron microscopy. 
Platelets were treated as described in Figure 22, those 
incubated with gold-labelled radioactive 3B3 being processed 
for TEM as described in Figure 15. Radioactivity associated 
with the cell pellets of two resin blocks was counted. The 
block with the largest cell pellet was sectioned for TEM. 
Hatched bars and open bars refer to iodinated 3B3 and iodinated 
3B3-gold, respectively. 
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Fig. 20. Pre-embedding of platelets with 3B3-gold. 
Platelets were incubated with iodinated 3B3 conjugated with 10 
nm gold and processed for TEM as described in the Methods. 
Cells were then sectioned and viewed in an attempt to detect 
the gold probe. No probe can be seen in any of the sections 
viewed despite the radioactivity associated with the tissue, 
indicating the presence of 3B3. The preparation yielded good 
ul trastructural detail especially with respect to membranes. 
Magnification: micrograph on left (30 OOOx), micrograph on 
right (50 OOOx). 
receptor-antibody complex. 
a post-embedding method. 
the Methods section. 
hydrophilic resins ( such 
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An alternative approach was to use 
The technique used is described in 
Usually, embedding the tissue in 
as LOWICRYL or LR WHITE) or using 
frozen, ul trathin sections processed on an ul tracryomicrotome 
give the best staining of antigens when using an irnrnunoprobe. 
These approaches were not feasible to the present study as 
facilities for cryosectioning were not available, and in any 
event, often provide poor membrane detail (42,46). Hydrophilic 
resins were not available for this study. 
The post-embedding approach is in many ways preferable to a 
pre-embedding technique. For instance, for the localisation of 
intracellular (i.e. not on the cell surf ace) antigens 
accessibility of the probe is often a problem, especially when 
the gold is large (5 nm diameter gold or smaller particles give 
adequate penetration). Often, the tissue has to be 
permeabilized with 
structures ( 6 0) . 
detergent, destroying some membrane 
3.4.4 (i) Irnrnunoreactivity of the antibodies: dot blot testing: 
Dot blots were performed as reported in Materials and Methods. 
Figure 21 shows results after testing the binding of a 5 nm 
gold-labelled goat anti-rabbit IgG ( GAR-5) to a rabbit anti-
mouse IgG (RAM). The RAM was used to target the 3B3 on the 
nitrocellulose. The blot indicated that the antibodies reacted 






90 µl STOCK 383 
10 µl STOCK 383 
0 µl STOCK 383 
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Fig. 21. Dot blot to test the immunoreactivity of a rabbit 
anti-mouse IgG against 3B3, visualised with 5 nm gold labelled 
Goat anti-rabbit IgG. 
3B3 was applied to a nitrocellulose membrane on a dot-blot 
apparatus and allowed to dry (A,B). The nitrocellulose was 
blocked with BSA for 30 minutes at room temperature and stained 
with rabbit anti-mouse IgG in the presence of 1 % normal goat 
serum. The nitrocellulose was then incubated overnight with a 
goat anti-rabbit IgG conjugated with 5 nm gold. The gold was 
enhanced as described in the Methods. A control of platelets 
with out 3B3 was used to show non-specific binding of gold-
labelled antibody (C). 
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A 
B • 0 
C 
Fig. 22. Dot blot to test inununoreactivity of GAM-10 run gold to 
3B3. 
Serial, double dilutions of affinity purified 3B3 (A), or 
affinity purified 3B3 labelled with radioactive iodine ( B), 
were applied to a nitrocellulose dot blot apparatus and allowed 
to dry. The nitrocellulose was then blocked with BSA for 30 
minutes at room temperature and stained with goat anti-mouse 
IgG conjugated to 10 nm gold (GAM-10) for 3 hours. The 
nitrocellulose was washed and developed with a silver 
enhancement stain in order to visualise the gold. 
Autoradiography was performed on the blot for 3 hours in order 
to visualise the radioactivity associated with the antibody 






90 µl STOCK 383 
10 µl STOCK 383 
0 µl STOCK 383 
Fig. 23. Dot blot to test innnunoreactivity of G.AM-10 run gold to 
3B3 bound to whole platelets. 
Platelets were labelled with two concentrations of 3B3 at 37°C 
for 45 minutes and washed. Platelets were then fixed with 
glutaraldehyde and incubated overnight with a lysine-containing 
solution to quench unlinked glutaraldehyde. Whole cells were 
then applied to a dot-blot apparatus and allowed to dry. The 
nitrocellulose was treated as described in Figure 19. Control 
platelets had no 3B3 in their incubation mix. 
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Figure 22 shows the reactivity of the 10 nm gold-labelled goat 
anti-mouse IgG (GAM-10) to 3B3 bound on the nitrocellulose. 
Both the 3B3, as well as the iodinated 3B3 were successfully 
targeted by the probe (A, 3B3; B, iodinated 3B3). (C) shows 
an autoradiograph of ( B) which correlates the amount of gold 
with the amount of antibody present. 
Figure 23 shows the reactivity of GAM-10 bound to whole cells. 
Binding was shown to be specific as demonstrated by the 
control. 
Discussion 
Two systems for post-embedding immunocytochemistry were tested'. 
A system using GAR-5 with RAM to target 3B3 would be preferable 
as it would give improved accessibility of the RAM to the 
antigen embedded in the tissue, as compared with an antibody 
bound to a relatively large gold molecule which may cause 
steric hindrance effects ( 60). Also, non-specific binding of 
the gold-labelled antibody was reduced. The GAM-10 system also 
proved to be feasible on the blots. 10 nm gold would be more 
easily visible in the TEM but this may be offset due to binding 
problems caused by the size of the gold particle. 
3 . 4 . 4 ( ii ) -=0-=-n=---'g=r=-=i-=-d=---------=i=mm=u=n=o=m=a=r::..:k-=-i=· ::.:n=g'-__.;;:o:...::f=---------'t::..:h-=-e"'---=r-"e....;:c~e::...pcc...t~o-=r'--....;:a=n=t-=-=i=b:...::o:....:d~y 
complex: Grids with ultrathin sections of platelets embedded in 
EPON-ARALDITE were treated as described. The sections stained 
with the RAM, GAR-5 system showed high levels of non-specific 
binding on the controls (sections of cells with no 3B3). 
Lengthening the blocking time and altering the 





The sections stained with GAM-10 are depicted in Figure 24. 
Binding of gold occurred in interior sites of the platelets in 
compartments morphologically similar to membranes of the 
canalicular system. The canalicular system appeared distended 
in many sections (similar to those in Figure 20). Some surface 
binding also occurred (arrows). The lumen of many of the 
canalicular system "vacuoles", especially the ones largely 
distended, contained a loosely packed, granular material that 
could either have been membrane of the canalicular system 
sectioned in the plane of its luminal surface, or interiorized 
material from the medium. The gold probe observed was in the 
form of single spheres (i.e. no clumping of gold had occurred) 
all on the luminal side of the membranes. The controls 
(platelets without 3B3) showed less than one probe bound per 
cell, with the gold often localized to the cytoplasm or a 
granule (Results not shown) . Contrast of the cells in the 
sections was poor due to the bleaching effect of the etching 
agent, H2o2 , on the osmium tetroxide and tannic acid stains. 
Apparent uniform staining of the extracellular environment was 
probably attributable to the lead citrate and uranyl acetate 
staining the etched resin. 
A B 
Fig. 24. Post-embedding immunocytochemistry. 
Blocks containing platelets incubated in 
absence of 3B3, were sectioned onto nickel 
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the presence and 
grids. Sections 
were etched with hydrogen peroxide and washed in Tris. 
Sections were then blocked with normal goat serum and stained 
with a polyclonal goat anti-mouse antibody conjugated with 10 
nm gold. After washing with Tris, the sections were fixed with 
glutaraldehyde and washed with distilled water. Contrasting 
with uranyl acetate and lead citrate followed. Platelets 
processed for results shown in Figure 23 were used as 3B3-
positive samples. B is an enlarged portion of A. 
Magnification: A (40 OOOx), B (80 OOOx), C (60 OOOx), D 
(40 OOOx), E (60 OOOx), F (100 OOOx). Arrows indicate surface 






Post-embedding irnmunocytochemistry of platelets incubated with 
3B3, using GAM-10 as a probe, was able to detect interiorized 
antibody in structures that clearly resemble the canalicular 
system of platelets. These structures can easily be 
distinguished from granules that were stained in a darker, more 
unif arm way. The binding of the probe was specific to cells 
incubated with 3B3. The probe was also exclusively found on 
the luminal aspect of the canalicular structures with no 
intracellular binding. The staining properties of all the 
structures in which probe was observed was consistent with that 
of the canalicular system. Very little probe was observed on 
the surface of the platelets. 
3.5 FEASIBILITY OF SURFACE MEMBRANE BIOTINYLATION AS A MARKER 
TO STUDY MEMBRANE INTERNALIZATION 
In order to reinforce the 
exogalactosylation technique, 




obtained using the 
feasibility of a 
internalization was 
investigated. Biotinylation of membrane proteins with NHS-SS-
Biotin would provide another covalent labelling technique. 
The biotin derivative NHS-SS-Biotin is membrane impermeable and 
reacts with primary amines. Biotinylated protein could be 
detected by binding iodinated streptavidin. The avidin-biotin 
interaction is the strongest known noncovalent biological 
recognition ( Ka = 1015 M-1) between protein and ligand. 
Streptavidin was more suitable for iodination as it contains 6 
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tyro sines per subunit in contrast to avidin ( 1 
tyrosine/subunit) ( 6 7) • Streptavidin is a 60 kD protein 
consisting of four identical subunits of 15 kD. Each subunit 
contains a single biotin binding site. Iodinated streptavidin 
had a specific activity of 0,52 x 105 cpm/µg. 
A reducing agent such as dithioerythritol (DTE) at a 
concentration above 0,37 µM (63) would then be used to remove 
accessible avidin-biotin by reduction of the disulphide bond in 
the spacer arm of the biotin analog. The amount of 
radioactivity remaining cell-associated would provide the basis 
for the internalization assay. 
Figure 25 shows that label could not be removed by treatment 
with DTE as the amount of radioactivity released after DTE 
treatment was the same as after washing in the absence of DTE 
( approximately O, 9 % ) • When mouse macrophages of the P388D1 
strain were used in an identical experiment, neither DTE nor 10 
mM .B-mercaptoethanol were able to remove more label than was 
washed off under non-reducing conditions. 
Discussion 
The biotinylation technique cannot be employed to measure 
membrane internalization. Agents that should have reduced the 
disulphide linkage did not do so. Radioactivity from the 
streptavidin bound to biotin was clearly discernible from that 
bound non-specifically. It is unclear as to why the reducing 
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Fig. 25. Biotinylation of cell-surface membranes using NHS-SS-
biotin. 
Human platelets or mouse macrophages were incubated in the 
presence (•) and absence (o) of NHS-SS-Biotin, for 1 hour on 
ice. After washing, streptavidin labelled with radioactive 
iodine was added for 30 minutes on ice. Cells were then washed 
and the amount of radioactivity remaining was measured at each 
step. After 4 washes, dithioerythritol (DTE) was added for 15 
minutes on ice, to remove accessible label. Wash number 5 
indicates radioactivity remaining after treatment with DTE. 
With platelets, error bars indicate the variation between 2 
samples. With macrophages, after the 5th wash, 10 mM fl-




There have been many studies involving platelets as endocytic 
and exocytic elements. It is apparent from morphometric 
studies that the platelet represents a vast area of membrane 
capable of interaction with elements in the surrounding plasma, 
especially if the membranes of the canalicular system are taken 
into account (4,32). A variety of ligands and particles have 
been used to study endocytic and pinocytic activity in 
platelets (9,11,12,19,36,38). Most of these workers indicate 
that platelets act in some way to take up particulate matter 
from surrounding fluid. More recent studies have involved 
uptake of specific plasma proteins by platelets and 
megakaryocytes (32,39,40,68) into intracellular sites. Coated 
pi ts and vesicles with an appearance different to clathrin-
coated membrane have been demonstrated in mammalian platelets 
(41). These have been implicated in the traffic of endocytosed 
proteins to granules. The ability of cells to acquire such 
proteins into secretory granules rarely has been reported (32). 
A recent review (32) has proposed a detailed and complex set of 
processes for the trafficking of endocytosed particulate and 
fluid-phase material within megakaryocytes and platelets. The 
role of the fibrinogen receptor, the GPIIbIIIa has long been 
understood to play a fundamental role with these processes 
(16,17,20,23,39,42). 
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Fibrinogen has been shown not to be synthesized by 
megakaryocytes. 
platelets has led 
endocytosis (39). 
been discussed in 
Its presence within secretory granules of 
to the proposal that uptake occurred by 
The importance of the canalicular system has 
this respect. It was demonstrated that 
fibrinogen-gold particles were cleared to the canalicular 
system, in a process independent of platelet activation (8). 
Platelet endocytosis has been studied using monoclonal and 
polyclonal antibodies to some membrane receptors. Monoclonals 
against GPIIbIIIa are recognised by the receptor as a ligand, 
and the receptor reacts by undergoing redistribution to an 
intracellular compartment. The effect is specific to this 
receptor, as monoclonals to another glycoprotein, GPib, do not 
cause any redistribution of the receptor with its II ligand 11 • 
The mechanism proposed to account for this phenomenon is 
endocytosis (24,42). 
The present study attempted to detect endocytic activity using 
covalent membrane markers and immunocytochemistry. A 
monoclonal antibody against the GPIIbIIIa, designated 3B3 (45), 
was used to detect the intracellular compartment to which the 
receptor was redistributed. Similar to a previous study (42), 
the 3B3 was shown to be internalized at 37°C to an 
intracellular compartment. Using a post-embedding 
immunocytochemical technique, the receptor-3B3 complex was 
demonstrated to be internalized to an intracellular, membrane-
bound compartment. However, the study failed to demonstrate 
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any uptake of labelled membrane concomitant with uptake of 
receptor-3B3. 
No membrane or fluid-phase internalization of a constitutive or 
basal nature could be observed in this study. The minute 
amount of fluid-phase uptake (Figure 10) was negligible when 
compared to pinocytic uptake measured in other cell types (cf. 
Table II). 
A model, proposed to deal with this apparent contradiction, is 
similar to that proposed by Wencel-Drake (42). This model is 
summarized in Figure 14. The present findings were in support 
of model B: GPIIbIIIa-3B3 complexes are cleared from the 
platelet surface and sequestered in the canalicular system. 
That all the labelled membrane could be removed, supports 
sequestration into the canalicular system, rather than 
endocytosis, which would render the internalized label 
inaccessible to enzymatic removal. The principal finding in 
support of endocytosis as proposed by Wencel-Drake (42) is that 
irnrnunof luorescent localization of the anti-GPIIbIIIa antibody 
was only possible when the membranes were permeabilised with 
the use of Tri ton. These findings can be accounted for by 
considering that fixation with paraformaldehyde probably 
resulted in closure of the channels at their point of access 
with the plasma membrane, by some kind of cross-linking effect. 
Thus, al though the 3B3 was redistributing to the interior of 
the cell, the membranes that accompanied it were still 
accessible to the cell medium. The term 11 interiorization" is 
thus preferable to II internalization 11 , the latter referring to 
87 
true endocytosis. Also, no difference in the labelling profile 
of membrane components could be demonstrated with cells 
labelled at 37°C (Figure 7), which is against a process of true 
endocytosis occurring. The observed redistribution of 
antibody-labelled GPIIbIIIa ( cf. Figure 13) can also be 
explained in terms of uptake into the canalicular system. 
The interior sites to which interiorized 3B3-receptor complexes 
were shown to redistribute are morphologically identical to 
structures of the canalicular system. It is thus proposed that 
the receptor-antibody complex undergoes a process of 
sequestration into the open canalicular system and not true 
endocytosis as was suggested by other authors. These findings 
are thus similar to studies on surface-activated platelets 
demonstrating sequestration of latex particles and fibrinogen-
gold complexes in the canalicular system (9,23). 
The present study did not attempt to measure interactions of 
platelets with f ibrinogen. Other authors who propose that 
platelets acquire granule f ibrinogen ( and other plasma 
proteins) by endocytosis (32,39,41,68) have demonstrated this 
to occur at the stage of megakaryocytes only. It is very 
likely that the megakaryocyte possesses all the machinery for 
true endocytosis. It can also be accepted that these cells 
actively employ endocytic mechanisms to acquire plasma proteins 
they cannot synthesize. These proteins may subsequently be 
found in the secretory granules of platelets. It is more 
likely, therefore, that the granule proteins ( as with other 
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platelet constituents) are inherited by the platelets when they 
are released into the circulation. 
The results of the present study indicate strongly that in 
human platelets the fate of GPIIbIIIa, labelled with 3B3, 
appears to be sequestration into the canalicular system. It is 
possible that other mechanisms exist for dealing with different 
types of particulate matter. Platelets in the resting state 
may respond to and deal with different ligands and particles in 
a separate way to platelets activated or bound to surfaces. 
The evidence presented in this study should be considered when 
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